The management programs are the fundation of the SWENOTECA collaboration. They provide clinician with guidelines for treating all patients with testicular cancer. Continous evaluation of result provide quality assurance for treatment given and also make it possible to evaluate adherence to the guidelines.

 

Norway and Sweden currently have the best survival in testicular cancer in the world, and we believe the close cooperation within the SWENOTECA has been an important factor in achieving this important goal.